Skip to main content
Journal cover image

Subtype-specific 3D genome alteration in acute myeloid leukaemia.

Publication ,  Journal Article
Xu, J; Song, F; Lyu, H; Kobayashi, M; Zhang, B; Zhao, Z; Hou, Y; Wang, X; Luan, Y; Jia, B; Stasiak, L; Wong, JH-Y; Wang, Q; Jin, Q; Jin, Q ...
Published in: Nature
November 2022

Acute myeloid leukaemia (AML) represents a set of heterogeneous myeloid malignancies, and hallmarks include mutations in epigenetic modifiers, transcription factors and kinases1-5. The extent to which mutations in AML drive alterations in chromatin 3D structure and contribute to myeloid transformation is unclear. Here we use Hi-C and whole-genome sequencing to analyse 25 samples from patients with AML and 7 samples from healthy donors. Recurrent and subtype-specific alterations in A/B compartments, topologically associating domains and chromatin loops were identified. RNA sequencing, ATAC with sequencing and CUT&Tag for CTCF, H3K27ac and H3K27me3 in the same AML samples also revealed extensive and recurrent AML-specific promoter-enhancer and promoter-silencer loops. We validated the role of repressive loops on their target genes by CRISPR deletion and interference. Structural variation-induced enhancer-hijacking and silencer-hijacking events were further identified in AML samples. Hijacked enhancers play a part in AML cell growth, as demonstrated by CRISPR screening, whereas hijacked silencers have a downregulating role, as evidenced by CRISPR-interference-mediated de-repression. Finally, whole-genome bisulfite sequencing of 20 AML and normal samples revealed the delicate relationship between DNA methylation, CTCF binding and 3D genome structure. Treatment of AML cells with a DNA hypomethylating agent and triple knockdown of DNMT1, DNMT3A and DNMT3B enabled the manipulation of DNA methylation to revert 3D genome organization and gene expression. Overall, this study provides a resource for leukaemia studies and highlights the role of repressive loops and hijacked cis elements in human diseases.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nature

DOI

EISSN

1476-4687

Publication Date

November 2022

Volume

611

Issue

7935

Start / End Page

387 / 398

Location

England

Related Subject Headings

  • Sequence Analysis
  • Reproducibility of Results
  • Promoter Regions, Genetic
  • Leukemia, Myeloid, Acute
  • Humans
  • Genome, Human
  • General Science & Technology
  • Gene Silencing
  • Gene Expression Regulation, Leukemic
  • Enhancer Elements, Genetic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Xu, J., Song, F., Lyu, H., Kobayashi, M., Zhang, B., Zhao, Z., … Yue, F. (2022). Subtype-specific 3D genome alteration in acute myeloid leukaemia. Nature, 611(7935), 387–398. https://doi.org/10.1038/s41586-022-05365-x
Xu, Jie, Fan Song, Huijue Lyu, Mikoto Kobayashi, Baozhen Zhang, Ziyu Zhao, Ye Hou, et al. “Subtype-specific 3D genome alteration in acute myeloid leukaemia.Nature 611, no. 7935 (November 2022): 387–98. https://doi.org/10.1038/s41586-022-05365-x.
Xu J, Song F, Lyu H, Kobayashi M, Zhang B, Zhao Z, et al. Subtype-specific 3D genome alteration in acute myeloid leukaemia. Nature. 2022 Nov;611(7935):387–98.
Xu, Jie, et al. “Subtype-specific 3D genome alteration in acute myeloid leukaemia.Nature, vol. 611, no. 7935, Nov. 2022, pp. 387–98. Pubmed, doi:10.1038/s41586-022-05365-x.
Xu J, Song F, Lyu H, Kobayashi M, Zhang B, Zhao Z, Hou Y, Wang X, Luan Y, Jia B, Stasiak L, Wong JH-Y, Wang Q, Jin Q, Fu Y, Yang H, Hardison RC, Dovat S, Platanias LC, Diao Y, Yang Y, Yamada T, Viny AD, Levine RL, Claxton D, Broach JR, Zheng H, Yue F. Subtype-specific 3D genome alteration in acute myeloid leukaemia. Nature. 2022 Nov;611(7935):387–398.
Journal cover image

Published In

Nature

DOI

EISSN

1476-4687

Publication Date

November 2022

Volume

611

Issue

7935

Start / End Page

387 / 398

Location

England

Related Subject Headings

  • Sequence Analysis
  • Reproducibility of Results
  • Promoter Regions, Genetic
  • Leukemia, Myeloid, Acute
  • Humans
  • Genome, Human
  • General Science & Technology
  • Gene Silencing
  • Gene Expression Regulation, Leukemic
  • Enhancer Elements, Genetic